Literature DB >> 1996642

Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation.

R A DeLa Cadena1, K J Laskin, R A Pixley, R B Sartor, J H Schwab, N Back, G S Bedi, R S Fisher, R W Colman.   

Abstract

The plasma kallikrein-kinin system is activated in Gram-negative sepsis and typhoid fever, two diseases in which bacterial products have been shown to initiate inflammation. Because a single intraperitoneal injection of bacterial cell wall peptidoglycan-polysaccharide polymers from group A steptococci (PG-APS) into a Lewis rat produces a syndrome of relapsing polyarthritis and anemia, we investigated changes in the role of the kallikrein-kinin system in this model of inflammation. Coagulation studies after injection of PG-APS revealed an immediate and persistent decrease in prekallikrein levels. High-molecular-weight kininogen levels decreased significantly during the acute phase and correlated with the severity of arthritis. Factor XI levels were decreased only during the acute phase. Antithrombin III levels remained unchanged, indicating that neither decreased hepatic synthesis nor disseminated intravascular coagulation caused the decreased plasma contact factors. Plasma T-kininogen (an acute phase protein) was significantly elevated during the chronic phase. PG-APS failed to activate the contact system in vitro. Thus the kallikrein-kinin system plays an important role in this experimental model of inflammation, suggesting that activation of this system may play a role in the pathogenesis of inflammatory bowel disease and rheumatoid arthritis in which bacterial products might be etiologically important.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1996642     DOI: 10.1152/ajpgi.1991.260.2.G213

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  Host Pathways of Hemostasis that Regulate Group A Streptococcus pyogenes Pathogenicity.

Authors:  Victoria A Ploplis; Francis J Castellino
Journal:  Curr Drug Targets       Date:  2020       Impact factor: 3.465

Review 2.  The plasma kallikrein-kinin system in sepsis, inflammatory arthritis, and enterocolitis.

Authors:  R W Colman; R B Sartor; A A Adam; R A DeLa Cadena; A Stadnicki
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 3.  Kallikrein-kinin in stem cell therapy.

Authors:  Julie Chao; Grant Bledsoe; Lee Chao
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

4.  A critical role for plasma kallikrein in the pathogenesis of autoantibody-induced arthritis.

Authors:  Aizhen Yang; Junsong Zhou; Bo Wang; Jihong Dai; Robert W Colman; Wenchao Song; Yi Wu
Journal:  FASEB J       Date:  2017-08-14       Impact factor: 5.191

5.  Role of plasma kallikrein-kinin system activation in synovial recruitment of endothelial progenitor cells in experimental arthritis.

Authors:  Jihong Dai; Alexis Agelan; Aizhen Yang; Viviana Zuluaga; Daniel Sexton; Robert W Colman; Yi Wu
Journal:  Arthritis Rheum       Date:  2012-11

6.  Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat.

Authors:  A Stadnicki; R A DeLa Cadena; R B Sartor; D Bender; C A Kettner; H C Rath; A Adam; R W Colman
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

7.  Adrenomedullin inhibits spontaneous and bradykinin-induced but not oxytocin- or prostaglandin F(2alpha)-induced periodic contraction of rat uterus.

Authors:  T Yanagita; R Yamamoto; T Sugano; H Kobayashi; Y Uezono; H Yokoo; S Shiraishi; S I Minami; A Wada
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

8.  A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.

Authors:  Ricardo G Espinola; Audrey Uknis; Irma M Sainz; Irma Isordia-Salas; Robin Pixley; Raul DeLa Cadena; Walter Long; Alexis Agelan; John Gaughan; Albert Adam; Robert W Colman
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

9.  Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth.

Authors:  S N Lichtman; E E Okoruwa; J Keku; J H Schwab; R B Sartor
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  Immunolocalization and expression of kallistatin and tissue kallikrein in human inflammatory bowel disease.

Authors:  Antoni Stadnicki; Urszula Mazurek; Maciej Gonciarz; Danuta Plewka; Grazyna Nowaczyk; Joanna Orchel; Ezbieta Pastucha; Andrzej Plewka; Tadcusz Wilczok; Robert W Colman
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.